Frontlight ResearchEarly access
Trial site
Goiânia
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease2 trials
- Stroke2 trials
- Chronic myeloid leukaemia1 trial
- Heart failure1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals7 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 18 Nov 2026